ConductScience.org, home

Paper31997014

Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease.

Cruz Rodriguez JB and 1 other. Curr Cardiol Rep, 2020. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease. Papers, record 31997014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31997014

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease.
PubMed
Journal
Curr Cardiol Rep
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2020-02-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cruz Rodriguez JBJose B
2Alkhateeb HHaider

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
Calcium Channel BlockersMajor topic
Cardiovascular AgentsMajor topic
Coronary Artery DiseaseMajor topic
Humans
Myocardial Infarction

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110073852Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.Am J Cardiol1999https://conductscience.org/library/papers/10073852PubMed
227539683
Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
JACC Cardiovasc Interv2016https://conductscience.org/library/papers/27539683PubMed
38682138
The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
Eur Heart J1996https://conductscience.org/library/papers/8682138PubMed
41732370Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination.J Am Coll Cardiol1992https://conductscience.org/library/papers/1732370PubMed
58614419The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.N Engl J Med1996https://conductscience.org/library/papers/8614419PubMed
615911902
A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
Psychosom Med2005https://conductscience.org/library/papers/15911902PubMed
72901501Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.JAMA1988https://conductscience.org/library/papers/2901501PubMed
829653999Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.Circ Cardiovasc Qual Outcomes2018https://conductscience.org/library/papers/29653999PubMed
98349377Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia.Int J Cardiol1993https://conductscience.org/library/papers/8349377PubMed
107721498Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.Int J Cardiol1995https://conductscience.org/library/papers/7721498PubMed
1125260718
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol2014https://conductscience.org/library/papers/25260718PubMed
1215351192Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.Lancet2004https://conductscience.org/library/papers/15351192PubMed
1322727237An international model to predict recurrent cardiovascular disease.Am J Med2012https://conductscience.org/library/papers/22727237PubMed
148279372Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris.Am J Cardiol1994https://conductscience.org/library/papers/8279372PubMed
1527650822β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.BMJ2016https://conductscience.org/library/papers/27650822PubMed
1615536108Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.JAMA2004https://conductscience.org/library/papers/15536108PubMed
1731080472Effect of β-blocker therapy in diabetic patients with stable coronary heart disease: a meta-analysis.J Geriatr Cardiol2019https://conductscience.org/library/papers/31080472PubMed
1816415069Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study.BMJ2006https://conductscience.org/library/papers/16415069PubMed
1925271049β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.Circ Cardiovasc Qual Outcomes2014https://conductscience.org/library/papers/25271049PubMed
208552787Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use.Prog Cardiovasc Dis1996https://conductscience.org/library/papers/8552787PubMed

See all 35 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
40042744Novel impact of metal ion-induced cell death on diabetic cardiomyopathy pathogenesis and therapy.Apoptosis2025https://conductscience.org/library/papers/40042744PubMed
39888363Exploring hypertension-linked diseases: a comprehensive review of innovative drug combinations with enhanced therapeutic potential.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39888363PubMed
39408034Under-Prescription of Drugs in the Elderly Population of Western Romania: An Analysis Based on STOPP/START Version 2 Criteria.J Clin Med2024https://conductscience.org/library/papers/39408034PubMed
35577079Molecular Determinants, Clinical Manifestations and Effects of Immunization on Cardiovascular Health During COVID-19 Pandemic Era - A Review.Curr Probl Cardiol2023https://conductscience.org/library/papers/35577079PubMed
34687320Initial in-hospital heart rate is associated with long-term survival in patients with acute ischemic stroke.Clin Res Cardiol2022https://conductscience.org/library/papers/34687320PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31997014

GET https://conductscience.org/api/papers/v1/31997014/references?page=2